Sales revenue decreased by 5% to $2,177 million in Q1 2026, down from $2,290 million in Q1 2025, primarily due to lower sales volume (-4%) and lower selling prices (-4%), partially offset by favorable foreign currency exchange impact (+3%). Net earnings attributable to Eastman fell by 41% to $107 million ($0.93 diluted EPS) in Q1 2026, compared to $182 million ($1.57 diluted EPS) in Q1 2025. Earnings before interest and taxes (EBIT) decreased by 38% to $188 million in Q1 2026 from $302 million in Q1 2025. Excluding non-core items, EBIT decreased by 36% to $200 million. The Chemical Intermediates segment reported a loss before interest and taxes of $18 million in Q1 2026, a significant decline from a $19 million gain in Q1 2025, primarily due to weak commodity market conditions and the impact of Winter Storm Fern. The Fibers segment experienced a 22% decrease in sales and a 49% decrease in EBIT, largely due to customer inventory destocking in acetate tow and the conflict in the Middle East. The Advanced Materials segment saw a 41% decrease in EBIT (excluding non-core items) due to unfavorable sales volume mix, capacity utilization, and lower selling prices, despite a favorable foreign currency exchange impact and IEEPA tariff refunds. Cash used in operating activities improved to $137 million in Q1 2026 from $167 million in Q1 2025, mainly due to lower variable compensation payouts. The company recognized a $22 million benefit in 'Cost of sales' in Q1 2026 due to court rulings establishing a legal right to a refund of International Emergency Economic Powers Act (IEEPA) tariffs. Eastman issued $600 million aggregate principal amount of 4.5% notes due February 2031, with net proceeds of $594 million, and repaid the remaining $150 million of the 2027 Term Loan.